• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Going beyond your intellect to engage customers

Going beyond your intellect to engage customers

August 19, 2009 By SeidlerBernstein Inc.

These days, you have to use everything you can to make the most of precious marketing dollars. So instead of relying on your intellect alone, why not leverage your five senses? You use sound, smell, touch, taste and sight more than you realize to dimensionalize your brand. But by being more deliberate, you can take your brand even further.

Be heard

For instance, suppose you make a surgical device with an auditory locking mechanism. Here, sound is an important part of your brand. Why not create a 3D mailer with a sound chip? Or perhaps you make a left ventricular assist device where quiet operation is an important differentiator — and key to patient adoption. How can you bring the sound of silence to life? By opening your ears, you can be heard more in the marketplace.

Let them feel your brand

We worked with a client that makes an adhesive mesh for surgical repair. To emphasize product integrity, we sent out samples that physicians could dip in liquid and test for strength. Don’t just talk about your product. Give customers a feel for it.

Show. Don’t tell.

For a mechanical thrombectomy device that’s incredibly easy to operate, we created booth graphics, a brochure and a cart chart that reflected this simplicity. They were clean-looking, with lots of white space, and very light on copy. It may not be easy to romance an innovative product with few words, but you know what they say: Seeing is believing.

Smells like BS

Okay, smell may not be the most useful sense for medical devices. You might find a way to use it for a nasal packing product, an endoscopic tool for nasal surgery or some other product that impacts the nose. But better make sure it’s smart and relevant, or your customers will smell something fishy.

Leave a good taste in their mouths

If all else fails, you can always offer better cookies than your competitors at a trade show. Or a locally produced healthy snack to illustrate your commitment to improving human health. By giving them a little taste of your hospitality, you can whet their appetites for something more.

Of course, we don’t want to minimize the importance of data and science in marketing your product. But if your shrinking budget is enough to make you lose your senses, just remember: It’s always an option to use them.

{IMAGELEFT:http://www.massdevice.com/sites/default/wp-content/uploads/headshots/See_Nik_100x100.jpg}Nik See is Seidler Bernstein’s director of brand planning & strategy. He has worked with a diverse list of organizations including Macy’s, Best Buy, Pillsbury, 3M, Cargill, Second Harvest, Ten Thousand Villages, Kohler, General Mills, Royal Caribbean International, Target Corporation and Levi’s. See earned a BS in Mass Communications and Advertising from St. Cloud State University. He speaks fluent Mandarin, Cantonese and Malay. See is a member of, and an active contributor to, the Taproot Foundation; he is also a member of the Design Management Institute, AIGA (formerly the American Institute of Graphic Arts), the Advertising Federation and the Asia Pacific Brand Council.

{IMAGELEFT:http://www.massdevice.com/sites/default/wp-content/uploads/headshots/Brubake_Tod_100x100.jpg}Tod Brubaker is the firm’s associate creative director for copy. His extensive experience includes group copy director, working on biotech and healthcare accounts such as Amgen and Xenogen, and running a freelance business, Penman, Ink where he wrote award-winning copy for Ethicon (J&J) and served other clients such as Eli Lilly and Pfizer. Tod has accumulated industry honors including Cannes, Clio and Addy awards, as well as top honors for print at the Johnson & Johnson James E. Burke Marketing Excellence Awards.

Filed Under: Business/Financial News

In case you missed it

  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
  • Nasdaq grants Titan Medical 180-day extension to regain compliance
  • Aerin Medical reports positive 4-year results for VivAer treatment
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
  • How medical device companies are responding to abortion bans

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS